Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Volumn 11, Issue 13 Pt 2, 2005, Pages

  Johnson, Bruce E ^a   Rabin, Michael S ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEX DIFFERENCE; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 24944450635     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.ccr-05-9001     Document Type: Review

References (8)